Abstract 77 Table 1

EndpointsDrug abuse donors
(n=45)
Non-high risk donors (n=473)P-value
1 Year Survival 93.3% 89.4% 0.413
3 Year Survival 86.7% 83.5% 0.681
1 Year Freedom from Any-Treated Rejection 86.1% 84.5% 0.969
1 Year Freedom from Acute Cellular Rejection 93.7% 93.3% 0.949
1 Year Freedom from Antibody-Mediated Rejection 93.3% 96.6% 0.289
1 Year Freedom from Infection 64.4% 55.6% 0.207
3 Year Freedom from CAV 86.7% 88.1% 0.733
3 Year Freedom from NF-MACE (myocardial infarction, new heart failure, coronary intervention, implantable cardioverter defibrillator/pacemaker implant, stroke). 95.6% 86.0% 0.087
Incidence of Primary Graft Dysfunction,% 4.4% 6.3% 1.000